Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | F10 | P00742 | 8/20 | 0.37 |
| ▸ | F2 | P00734 | 6/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | WDR5 | P61964 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9715241 | 0.82 | F2 (0.38) | F2SLC1A2 | |
| Hydrochloric Acid SCHEMBL9715397 | 0.81 | F10 (0.42) | F10F2 | |
| SCHEMBL12137652 | 0.78 | P2RX7 (0.38) | F10 | |
| SCHEMBL17586128 | 0.74 | HDAC1 (0.40) | — | |
| SCHEMBL27182150 | 0.74 | GLS (0.30) | — | |
| SCHEMBL20382338 | 0.74 | — | — | |
| SCHEMBL13198116 | 0.74 | KLK1 (0.32) | F2 | |
| SCHEMBL16213058 | 0.72 | HDAC1 (0.38) | — | |
| SCHEMBL26729992 | 0.71 | LMNA (0.37) | TP53KMT2AGAACA12CA1 | |
| SCHEMBL13404895 | 0.70 | MGLL (0.37) | KMT2ACA12CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160074541-A1 | Prosthetic Compounds for Labeling Internalizing Biomolecules | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160074541-A1 | Prosthetic Compounds for Labeling Internalizing Biomolecules | CD47, CD2, CD22 | SLC7A5 523/4885F10 2466/4885F2 3597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.